These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 14534045)

  • 1. Evidence-based approach of the use of Botulinum toxin type A (BTX) in cerebral palsy.
    Wong V
    Pediatr Rehabil; 2003; 6(2):85-96. PubMed ID: 14534045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation.
    Houltram J; Noble I; Boyd RN; Corry I; Flett P; Graham HK
    Eur J Neurol; 2001 Nov; 8 Suppl 5():194-202. PubMed ID: 11851748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option.
    Kirschner J; Berweck S; Mall V; Korinthenberg R; Heinen F
    J Neurol; 2001 Apr; 248 Suppl 1():28-30. PubMed ID: 11357236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study.
    Franzén M; Hägglund G; Alriksson-Schmidt A
    BMC Musculoskelet Disord; 2017 Dec; 18(1):520. PubMed ID: 29228927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review.
    Boyd RN; Hays RM
    Eur J Neurol; 2001 Nov; 8 Suppl 5():1-20. PubMed ID: 11851730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy.
    Graham HK; Aoki KR; Autti-Rämö I; Boyd RN; Delgado MR; Gaebler-Spira DJ; Gormley ME; Guyer BM; Heinen F; Holton AF; Matthews D; Molenaers G; Motta F; García Ruiz PJ; Wissel J
    Gait Posture; 2000 Feb; 11(1):67-79. PubMed ID: 10664488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin a treatment in children with cerebral palsy: its effects on walking and energy expenditure.
    Balaban B; Tok F; Tan AK; Matthews DJ
    Am J Phys Med Rehabil; 2012 Jan; 91(1):53-64. PubMed ID: 22157436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial.
    Koman LA; Brashear A; Rosenfeld S; Chambers H; Russman B; Rang M; Root L; Ferrari E; Garcia de Yebenes Prous J; Smith BP; Turkel C; Walcott JM; Molloy PT
    Pediatrics; 2001 Nov; 108(5):1062-71. PubMed ID: 11694682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
    Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
    Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of botulinum toxin (BTX-A) on spasticity of the lower limb and on gait in cerebral palsy.
    Preiss RA; Condie DN; Rowley DI; Graham HK
    J Bone Joint Surg Br; 2003 Sep; 85(7):943-8. PubMed ID: 14516023
    [No Abstract]   [Full Text] [Related]  

  • 11. Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure.
    Linder M; Schindler G; Michaelis U; Stein S; Kirschner J; Mall V; Berweck S; Korinthenberg R; Heinen F
    Eur J Neurol; 2001 Nov; 8 Suppl 5():120-6. PubMed ID: 11851740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic properties and functional changes in spastic muscle after application of BTX-A in children with cerebral palsy: systematic review.
    García Salazar LF; dos Santos GL; Pavão SL; Rocha NA; de Russo TL
    Dev Neurorehabil; 2015 Feb; 18(1):1-14. PubMed ID: 25180438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of the effects of casting on equinus in children with cerebral palsy: an evidence report of the AACPDM.
    Blackmore AM; Boettcher-Hunt E; Jordan M; Chan MD
    Dev Med Child Neurol; 2007 Oct; 49(10):781-90. PubMed ID: 17880650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin injections minimally affect modelled muscle forces during gait in children with cerebral palsy.
    Wesseling M; Kainz H; Hoekstra T; Van Rossom S; Desloovere K; De Groote F; Jonkers I
    Gait Posture; 2020 Oct; 82():54-60. PubMed ID: 32892101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of botulinum toxin A lower limb injections in addition to physiotherapy approaches in children with cerebral palsy: A systematic review.
    Yana M; Tutuola F; Westwater-Wood S; Kavlak E
    NeuroRehabilitation; 2019; 44(2):175-189. PubMed ID: 30856126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type A injection for management of upper limb spasticity in children with cerebral palsy: a literature review.
    Park ES; Rha DW
    Yonsei Med J; 2006 Oct; 47(5):589-603. PubMed ID: 17066503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AACPDM systematic review of the effectiveness of therapy for children with cerebral palsy after botulinum toxin A injections.
    Lannin N; Scheinberg A; Clark K
    Dev Med Child Neurol; 2006 Jun; 48(6):533-9. PubMed ID: 16700950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of botulinum toxin A (Botox) injections used to treat limb spasticity on speech patterns in children with dysarthria and cerebral palsy: A report of two cases.
    Workinger MS; Kent RD; Meilahn JR
    J Pediatr Rehabil Med; 2017 May; 10(2):137-143. PubMed ID: 28582880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated botulinum toxin type a treatment in children with cerebral palsy?
    Bar-On L; Van Campenhout A; Desloovere K; Aertbeliën E; Huenaerts C; Vandendoorent B; Nieuwenhuys A; Molenaers G
    Arch Phys Med Rehabil; 2014 Mar; 95(3):515-23. PubMed ID: 23994052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral palsy and bruxism: Effects of botulinum toxin injections-A randomized controlled trial.
    Cahlin BJ; Lindberg C; Dahlström L
    Clin Exp Dent Res; 2019 Oct; 5(5):460-468. PubMed ID: 31687178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.